tert-Butyl (14-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3,6,9,12-tetraoxatetradecyl)carbamate

Catalog No. :
ACXUKR376
CAS No. :
2517592-97-9
Molecular Formula :
C19H32N2O8
Molecular Weight :
416.47

IUPAC Name:tert-butyl (14-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3,6,9,12-tetraoxatetradecyl)carbamate

tert-Butyl (14-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3,6,9,12-tetraoxatetradecyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$402.00Login to see priceInquiryInquiry
250mg98%$637.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (14-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3,6,9,12-tetraoxatetradecyl)carbamate
IUPAC Nametert-butyl (14-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3,6,9,12-tetraoxatetradecyl)carbamate
Molecular FormulaC19H32N2O8
Molecular Weight416.47
SMILESO=C(OC(C)(C)C)NCCOCCOCCOCCOCCN1C(C=CC1=O)=O
InChI KeyUEPNBMXPNMFODO-UHFFFAOYSA-N
SynonymMal-PEG4-NH-Boc
CAS No.2517592-97-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACXUKR376 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEZPG865 route compound structure diagram
    ACEZPG8651404111-67-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXUKR376 route product structure diagram
    ACXUKR3762517592-97-9
Inquiry

2. ACXUKR376 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKFIC952 route compound structure diagram
    ACKFIC952811442-84-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXUKR376 route product structure diagram
    ACXUKR3762517592-97-9
Inquiry

Comments (0)